Skip to content
KFF Health News KFF Health News KFF Health News KFF Health News
Donate
  • Donate
  • Connect With Us:
  • Contact
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS
  • Trump 2.0
  • Public Health
  • Race & Health
  • Audio
    • KFF Health News Minute
    • What the Health
    • An Arm and a Leg
    • Silence in Sikeston
    • Epidemic
    • American Diagnosis
    • Where It Hurts
  • Investigations
    • Bill Of The Month
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Payback: Tracking Opioid Cash
    • Systemic Sickness
    • The Injured
    • The Only Hospital in Town
    • ALL INVESTIGATIONS
  • More Topics
    • Abortion
    • Aging
    • Climate
    • COVID-19
    • Health Care Costs
    • Insurance
    • Medicaid
    • Medicare
    • Mental Health
    • Pharma
    • Rural Health
    • Uninsured

Search Results

Filter Results

Reset filters
Date
Custom Date Range
Topic
Content Type

Showing 161-180 of 202 results for "Liz Szabo"

Sort by

Never Too Late To Operate? Surgery Near End Of Life Is Common, Costly

By Liz Szabo February 28, 2018 KFF Health News Original

Nearly 1 in 3 Medicare patients undergo an operation in their final year of life.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Trump Vows (Again) To Lower Drug Prices But Skeptics Doubt Much Will Change

By Sarah Jane Tribble and Liz Szabo May 11, 2018 KFF Health News Original

President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

How The Shutdown Might Affect Your Health

By KFF Health News Staff January 19, 2018 KFF Health News Original

For some federal health programs, a shuttered government means business as usual. But the congressional impasse over funding will hit others hard.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Near Incineration Of Psychiatric Hospital Highlights Gaping Need For More Beds

By Barbara Feder Ostrov December 21, 2017 KFF Health News Original

Fire almost destroyed one of two acute care facilities in Ventura County — wiping out most of the region’s inpatient capacity. In California and nationally, such hospitals are strained by demand — and disasters.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Doing More Harm Than Good? Epidemic of Screening Burdens Nation’s Older Patients

By Liz Szabo December 20, 2017 KFF Health News Original

Patients are often aggressively screened for cancer, even if they won’t live long enough to benefit.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

FDA Head Vows To Tackle High Drug Prices And Drugmakers ‘Gaming The System’

By Sarah Jane Tribble and Liz Szabo February 15, 2018 KFF Health News Original

In an exclusive interview, FDA Commissioner Scott Gottlieb describes what he’s doing to spur competition and bring down drug prices.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Tanta atención que duele: terapias y cirugías innecesarias agregan dolor y enfermedad

By Liz Szabo October 23, 2017 KFF Health News Original

Las pruebas excesivas de cáncer de tiroides, próstata, seno y piel lleva a muchas personas mayores a someterse a tratamientos que no prolongarán sus vidas, pero que pueden causar dolor y sufrimiento innecesarios.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

So Much Care It Hurts: Unneeded Scans, Therapy, Surgery Only Add To Patients’ Ills

By Liz Szabo October 23, 2017 KFF Health News Original

Overtreatment of breast cancer and other diseases is pervasive, burdening patients and the health care system with enormous costs and needless suffering.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Cascade of Costs Could Push New Gene Therapy Above $1 Million Per Patient

By Liz Szabo October 17, 2017 KFF Health News Original

The costs of using a new class of cancer treatments include far more than the drug’s sticker price.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

First Edition: June 5, 2018

June 5, 2018 Morning Briefing

DID YOU TAKE YOUR VITAMINS? If so, you are one among millions of Americans. But what evidence is there that they ward off chronic disease? Tune in to the next KHN Facebook Live on Wednesday, June 6, at 3 p.m. ET, when senior correspondent Liz Szabo will separate fact from fiction. You can submit your questions and watch here.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Algunos pacientes con cáncer de tiroides pueden retrasar la cirugía

By Liz Szabo August 31, 2017 KFF Health News Original

Alrededor de un tercio de los pacientes con un tumor de tiroides de crecimiento lento, llamado cáncer de tiroides papilar, son elegibles para retrasar el tratamiento, según un nuevo estudio.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Some Thyroid Cancer Patients Can Safely Delay Surgery

By Liz Szabo August 31, 2017 KFF Health News Original

Study suggests that many small tumors are sleepy, not deadly.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Pioneering Cancer Gene Therapy Gets Green Light — And $475,000 Price Tag

By Liz Szabo August 30, 2017 KFF Health News Original

The USA’s first approved gene therapy — to be used to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Nueva droga contra la leucemia ofrece esperanza, pero a un costo millonario

By Liz Szabo August 23, 2017 KFF Health News Original

El tratamiento con una nueva droga del laboratorio Novartis para casos en los que ha fracasado la quimioterapia o el trasplante de médula costaría $649,000.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost

By Liz Szabo August 23, 2017 KFF Health News Original

A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Depression Among Heart Attack Survivors Can Be Deadly, Yet Is Often Ignored

By Liz Szabo July 20, 2017 KFF Health News Original

One in 5 heart attack patients suffers from severe depression, yet many get little or no treatment that could ease their suffering or save their lives.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Senate GOP Bill Aims To Add Psych Beds; Squeeze On Medicaid Signals Their Undoing

By Liz Szabo July 10, 2017 KFF Health News Original

The Senate health care bill has a provision to increase hospital beds for psychiatric care, but overall cuts in Medicaid could lead to even fewer beds nationwide.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

“¿Cuánto tiempo me queda, doctor?” Por qué muchos pacientes con cáncer no obtienen respuestas

By Liz Szabo June 12, 2017 KFF Health News Original

Muchas veces los pacientes con cáncer no reciben respuestas adecuadas a preguntas críticas, entre ellas, la más crucial y universal de todas.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

‘How Long Have I Got, Doc?’ Why Many Cancer Patients Don’t Have Answers

By Liz Szabo June 12, 2017 KFF Health News Original

Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

As Government-Funded Cancer Research Sags, Scientists Fear U.S. Is ‘Losing Its Edge’

By Liz Szabo June 2, 2017 KFF Health News Original

More of the research studies being presented at the world’s largest annual gathering of cancer scientists comes from abroad.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
  • Previous
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next

More From KFF Health News

In Axing mRNA Contract, Trump Delivers Another Blow to US Biosecurity, Former Officials Say

A photo of a nurse helping a young boy use an asthma inhaler.

In a Dusty Corner of California, Trump’s Threatened Cuts to Asthma Care Raise Fears

KFF Health News' 'What the Health?': Trump’s ‘One Big Beautiful Bill’ Lands in Senate. Our 400th Episode!

A colorfully decorated SUV is parked beside a white truck.

Trump Decried Crime in America, Then Gutted Funding for Gun Violence Prevention

KFF

© 2025 KFF. All rights reserved.

  • About Us
  • Donate
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Staff
  • Republish Our Content
  • Email Sign-Up
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS

Powered by WordPress VIP

Thank you for your interest in supporting Kaiser Health News (KHN), the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of all sizes and in communities large and small. We appreciate all forms of engagement from our readers and listeners, and welcome your support.

KHN is an editorially independent program of KFF (Kaiser Family Foundation). You can support KHN by making a contribution to KFF, a non-profit charitable organization that is not associated with Kaiser Permanente.

Click the button below to go to KFF’s donation page which will provide more information and FAQs. Thank you!

Continue